Not every pharmacist or healthcare provider can distribute Abstral® (fentanyl sublingual tablets). This prescription pain medication is only available through a special program, called the Abstral Risk Evaluation and Mitigation Strategy (REMS) program. This program helps describe the risks and benefits of using this strong narcotic drug.
Before a healthcare provider can prescribe this medication, he or she must enroll in this program, and so must the pharmacy that dispenses the drug. In addition, before people can receive this painkiller, they must enroll in the Abstral REMS program and sign an agreement stating that they understand how to use it.
This program is intended to help reduce the risks associated with taking Abstral, including the risks for abuse, misuse, and overdose.
(To learn more about the Abstral REMS program, click Abstral Uses. This article explains the steps that must be taken to use this medication and describes how Abstral works.)